LIPU-MB using a skull-implantable ultrasound device transiently opens the blood–brain
barrier allowing for safe, repeated penetration of cytotoxic drugs into the brain.
This study has prompted a subsequent phase 2 study combining LIPU-MB with albumin-bound
paclitaxel plus carboplatin (NCT04528680), which is ongoing.